Latest Piperazines Stories
redOrbit Staff & Wire Reports - Your Universe Online More than 100 influential oncologists from over 15 different countries have joined forces to demand pharmaceutical companies reduce the prices of potentially life-saving cancer medication, some of which can cost patients in excess of $100,000 per year. In a commentary published Thursday by Blood, the journal of the American Society of Hematology, 120 doctors and researchers specializing in the treatment of chronic myeloid leukemia...
Increasing, unsustainable prices for leukemia drugs represent larger issue across all cancers The increasing cost of treatments for chronic myeloid leukemia (CML) in the United States has reached unsustainably high levels and may be leaving many patients under- or untreated because they cannot afford care, according to a Blood Forum article supported by nearly 120 CML experts from more than 15 countries on five continents and published online today in Blood, the Journal of the American...
A Live Telephone/Web Education Program Offering Live Spanish Interpretation Featuring International CML Expert Jorge Cortes, MD WHITE PLAINS, N.Y., April 5, 2013 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) is committed to bringing the most current information about blood cancers to all patients and is pleased to announce a unique educational opportunity for Spanish-speaking patients with chronic myeloid leukemia (CML). On Wednesday, April 17, from 1:00 to 2:00 PM Eastern Time,...
Boston Medical Group the world's leader in men's sexual performance is expanding by adding an office in Columbia, MD. Columbia, MD (PRWEB) March 19, 2013 Boston Medical Group has added a new clinic to its nationwide network of clinics, specializing in the unique niche area of men’s sexual health. Erectile dysfunction (ED) and premature ejaculation (PE) have long been problems for millions of men nationwide. In spite of the availability of medications such as Viagra, Levitra and...
The Rottenstein Law Group, a Pradaxa law firm, acknowledges that the FDA has conducted extensive research into the topic, but the firm is still actively monitoring reports of side effects and filing lawsuits on behalf of clients who believe that Pradaxa injured them. (PRWEB) March 15, 2013 Although there have been numerous Pradaxa lawsuits because of the anticoagulant drug’s alleged excessive bleeding side effects, the U.S. Food and Drug Administration issued a report* this week...
OTTAWA, March 15, 2013 /CNW/ - The issue: An unauthorized natural health product, "Libigrow" was tested by Health Canada and found to contain hidden ingredients (sildenafil and tadalafil) that may pose serious risks to the health of Canadians. "Libigrow" was being sold at two retail locations in the province of Québec: Boutique Sexie folie Inc. (Sainte-Catherine) and at Boutique Érotique 5ième avenue Inc. (Valleyfield). This product is promoted as a male sexual...
A study published this week in PLOS Medicine finds that while antipsychotic medications are associated with small-to-moderate improvements in depressive symptoms in adults, there is little evidence for improvement on measures of quality of life and these medications are linked to adverse events such as weight gain and sedation. The results of the study, conducted by Glen Spielmans of Metropolitan State University in St. Paul, Minnesota and colleagues, have potential implications for the...
redOrbit Staff & Wire Reports - Your Universe Online A commonly-prescribed antibiotic could trigger potentially fatal irregular heart rhythms in some patients, officials from the US Food and Drug Administration (FDA) warned on Tuesday. Azithromycin, which is commonly sold as Zithromax or Zmax and is sometimes referred to as a “Z-Pack,” could cause the condition in patients who have an elevated risk of developing cardiovascular problems, reports Deborah Kotz of the Boston Globe....
Pain reduction effects of ranolazine most pronounced in patients with poor glucose control A commonly used anti-anginal drug reduces chest pain in patients with type 2 diabetes and appears to have a more pronounced effect in those with poorer glucose control, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. Ranolazine is approved by the U.S. Food and Drug Administration for the treatment of chronic angina, or chest pain, both...
redOrbit Staff & Wire Reports - Your Universe Online Taking a popular type of erectile dysfunction drug will not help patients suffering from a specific type of heart failure from increasing the maximum amount of physical exertion that they can withstand, according to a new study published Monday in the online edition of JAMA. The results of the (RELAX) study, determined that individuals who have heart failure with preserved ejection fraction (HFPEF) – a condition in which the...
